Expression of CHI3L1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

CHI3L1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 595.67

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

4051.3

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	37648.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	26792.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	22495.6
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	18952.0
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	17721.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	17311.8
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	17002.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	16181.2
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	15514.4
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	14595.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	14256.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	12973.1
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	11123.3
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	10825.9
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	10801.4
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	10785.9
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	10195.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	9264.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	9160.9
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	8651.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	8607.4
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	8543.0
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	8306.8
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	7731.9
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	7638.1
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	7212.0
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	6386.0
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	6119.0
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	5779.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	5659.8
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	5441.4
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	5186.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	5106.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	5068.0
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	5041.4
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	4930.5
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	4926.1
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	4916.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	4811.7
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	4756.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	4588.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	4514.3
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	4229.9
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3904.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3781.2
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3739.9
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	3724.8
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	3593.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	3556.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	3547.8
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	3537.1
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	3147.8
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	3082.6
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	3016.2
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2984.9
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2979.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2961.3
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	2950.7
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2808.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2758.0
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2505.1
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2489.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2322.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2290.8
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2213.2
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2045.7
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1985.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1943.8
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1804.9
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1697.8
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1642.4
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	1622.8
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1604.2
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	1526.4
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1477.5
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1465.9
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1441.3
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1365.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1357.9
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1331.9
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1312.8
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1277.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1207.9
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	1144.8
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1133.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1131.0
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1000.9
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	991.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	949.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	890.9
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	864.3
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	863.8
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	846.9
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	789.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	783.8
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	724.7
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	723.6
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	709.5
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	670.0
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	669.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	648.5
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	627.0
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	626.1
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	615.3
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	596.6
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	595.7
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	573.6
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	522.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	495.5
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	481.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	470.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	441.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	407.4
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	406.1
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	372.1
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	348.0
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	339.4
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	333.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	327.0
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	261.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	258.7
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	230.3
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	226.3
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	218.1
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	216.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	208.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	203.7
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	203.6
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	180.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	132.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	132.5
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	115.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	113.8
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	109.4
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	102.0
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	99.7
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	92.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	84.2
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	74.9
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	55.9
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	39.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

CHI3L1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 226.24

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2174.2

Number of samples

Samples

Sample	Description	pTPM
AK091	N, NA, stage:NA, dead, 210 days	13577.4
AK055	N, NA, stage:NA, dead, 240 days	10573.7
AK205	N, NA, stage:NA, dead, 120 days	9978.7
AK227	N, NA, stage:NA, alive, 300 days	9920.0
AK236	N, NA, stage:NA, dead, 360 days	8571.7
AK072	N, NA, stage:NA, dead, 150 days	7888.3
AK153	N, NA, stage:NA, dead, 240 days	7448.4
AK188	N, NA, stage:NA, alive, 420 days	6133.8
AK005	N, NA, stage:NA, dead, 240 days	5880.7
AK071	N, NA, stage:NA, dead, 540 days	5773.1
AK139	N, NA, stage:NA, dead, 270 days	5456.1
AK117	N, NA, stage:NA, dead, 210 days	3254.7
AK183	N, NA, stage:NA, alive, 360 days	2445.1
AK003	N, NA, stage:NA, dead, 600 days	2277.1
AK178	N, NA, stage:NA, dead, 240 days	2200.7
AK133	N, NA, stage:NA, dead, 360 days	2135.3
AK167	N, NA, stage:NA, dead, 180 days	1728.0
AK218	N, NA, stage:NA, dead, 180 days	1454.6
AK195	N, NA, stage:NA, dead, 390 days	1318.8
AK142	N, NA, stage:NA, alive, 90 days	1297.4
AK103	N, NA, stage:NA, alive, 1320 days	1236.3
AK074	N, NA, stage:NA, alive, 300 days	1206.4
AK089	N, NA, stage:NA, dead, 330 days	1139.5
AK030	N, NA, stage:NA, dead, 120 days	1122.0
AK100	N, NA, stage:NA, alive, 960 days	1012.4
AK035	N, NA, stage:NA, dead, 210 days	878.4
AK076	N, NA, stage:NA, alive, 660 days	846.9
AK216	N, NA, stage:NA, dead, 360 days	783.8
AK149	N, NA, stage:NA, dead, 420 days	772.6
AK226	N, NA, stage:NA, dead, 360 days	730.4
AK231	N, NA, stage:NA, dead, 240 days	675.6
AK123	N, NA, stage:NA, dead, 180 days	631.3
AK199	N, NA, stage:NA, alive, 1860 days	539.5
AK049	N, NA, stage:NA, dead, 180 days	533.4
AK051	N, NA, stage:NA, dead, 360 days	509.4
AK099	N, NA, stage:NA, dead, 420 days	501.8
AK088	N, NA, stage:NA, dead, 360 days	434.3
AK079	N, NA, stage:NA, dead, 210 days	415.6
AK173	N, NA, stage:NA, dead, 180 days	392.8
AK165	N, NA, stage:NA, alive, 360 days	378.3
AK043	N, NA, stage:NA, alive, 660 days	287.3
AK081	N, NA, stage:NA, dead, 180 days	285.7
AK053	N, NA, stage:NA, dead, 300 days	245.2
AK158	N, NA, stage:NA, dead, 360 days	229.5
AK085	N, NA, stage:NA, alive, 660 days	223.0
AK134	N, NA, stage:NA, dead, 360 days	221.0
AK006	N, NA, stage:NA, dead, 360 days	156.8
AK098	N, NA, stage:NA, dead, 660 days	99.4
AK041	N, NA, stage:NA, alive, 810 days	89.9
AK185	N, NA, stage:NA, alive, 330 days	67.4
AK156	N, NA, stage:NA, dead, 330 days	60.1
AK068	N, NA, stage:NA, alive, 360 days	33.4
AK066	N, NA, stage:NA, alive, 960 days	16.3
AK015	N, NA, stage:NA, alive, 720 days	11.6
AK124	N, NA, stage:NA, alive, 1920 days	9.6
AK102	N, NA, stage:NA, alive, 1740 days	9.3
AK002	N, NA, stage:NA, dead, 570 days	4.7
AK213	N, NA, stage:NA, alive, 2010 days	1.1
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0123530003	Tumor	2.3
CPT0206230003	Tumor	2.2
CPT0087570003	Tumor	2.2
CPT0190360004	Tumor	2.1
CPT0168590003	Tumor	1.8
CPT0219080004	Tumor	1.8
CPT0127480003	Tumor	1.4
CPT0206450003	Tumor	1.3
CPT0167640003	Tumor	1.3
CPT0218690004	Tumor	1.2
CPT0206880003	Tumor	1.1
CPT0092440003	Tumor	1.1
CPT0206560003	Tumor	1.1
CPT0093550003	Tumor	1.0
CPT0217000004	Tumor	1.0
CPT0168080003	Tumor	0.9
CPT0167750004	Tumor	0.9
CPT0167970003	Tumor	0.9
CPT0205570003	Tumor	0.8
CPT0186100003	Tumor	0.7
CPT0093590003	Tumor	0.7
CPT0079790003	Tumor	0.6
CPT0125570003	Tumor	0.5
CPT0196850003	Tumor	0.5
CPT0206000004	Tumor	0.5
CPT0093510003	Tumor	0.5
CPT0206110003	Tumor	0.4
CPT0189460003	Tumor	0.4
CPT0224540004	Tumor	0.4
CPT0162100003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0093360003	Tumor	0.3
CPT0168270003	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0089150003	Tumor	0.3
CPT0218890004	Tumor	0.3
CPT0221180003	Tumor	0.2
CPT0218830004	Tumor	0.1
CPT0162020003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0168480003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0216920008	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0189850004	Tumor	-0.2
CPT0205450004	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0168830003	Tumor	-0.2
CPT0225760003	Tumor	-0.2
CPT0205890003	Tumor	-0.3
CPT0127420003	Tumor	-0.3
CPT0218960004	Tumor	-0.4
CPT0224600003	Tumor	-0.4
CPT0225730003	Tumor	-0.4
CPT0218330004	Tumor	-0.5
CPT0093450003	Tumor	-0.5
CPT0002410011	Tumor	-0.5
CPT0071100003	Tumor	-0.5
CPT0201710003	Tumor	-0.7
CPT0224390004	Tumor	-0.8
CPT0205670004	Tumor	-0.8
CPT0171580008	Tumor	-0.8
CPT0078580003	Tumor	-0.8
CPT0205780003	Tumor	-0.8
CPT0167530003	Tumor	-0.8
CPT0189250003	Tumor	-0.8
CPT0182580003	Tumor	-0.9
CPT0104220003	Tumor	-0.9
CPT0168720003	Tumor	-0.9
CPT0217060003	Tumor	-0.9
CPT0175060003	Tumor	-0.9
CPT0125220003	Tumor	-0.9
CPT0217430008	Tumor	-0.9
CPT0206330003	Tumor	-0.9
CPT0206780003	Tumor	-1.0
CPT0224330003	Tumor	-1.0
CPT0204370003	Normal	-1.0
CPT0204380003	Normal	-1.2
CPT0204330003	Normal	-1.2
CPT0125510003	Tumor	-1.3
CPT0206670004	Tumor	-1.3
CPT0217710008	Tumor	-1.3
CPT0204350003	Normal	-1.4
CPT0204340003	Normal	-1.5
CPT0207030003	Tumor	-1.5
CPT0217100003	Tumor	-1.5
CPT0208980003	Tumor	-1.5
CPT0182550003	Tumor	-1.5
CPT0204360003	Normal	-1.5
CPT0228220003	Tumor	-1.6
CPT0204390003	Normal	-1.6
CPT0217880003	Tumor	-1.6
CPT0087680003	Tumor	-1.6
CPT0218670003	Tumor	-1.6
CPT0218770003	Tumor	-1.6
CPT0104330003	Tumor	-1.7
CPT0207090003	Tumor	-1.7
CPT0162140003	Tumor	-1.7
CPT0199770003	Tumor	-1.7
CPT0217190003	Tumor	-1.7
CPT0204420003	Normal	-1.8
CPT0204400003	Normal	-2.0
CPT0189570004	Tumor	-2.0
CPT0167860004	Tumor	-2.1
CPT0161730003	Tumor	-2.6
CPT0204410003	Normal	-2.7
CPT0190240004	Tumor	-2.9
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis